EVIO, Inc. (EVIO)
EVIO, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Henderson, NV, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $959,685. On trailing twelve-month figures it carries a trailing P/E of 1.67, a net margin of 3.0%. Its beta of -2.39 implies it has historically moved less than the broad market.
EVIO, Inc., along with its affiliates, provides specialized analytical testing and expert advisory services to the cannabis industry throughout the United States. The company's consulting expertise spans strategic guidance, product formulation assistance, and comprehensive support for licensing and regulatory compliance. Furthermore, EVIO conducts a full range of laboratory analyses, including cannabinoid potency assessment, terpene profiling, pesticide screening, residual solvent detection, visual inspections, and biological contaminant testing. The firm maintains its headquarters in Henderson, Nevada.
EVIO, Inc. is most often compared with the following Healthcare names: